Azilsartan increases levels of IL-10, down-regulates MMP-2, MMP-9, RANKL/RANK, Cathepsin K and up-regulates OPG in an experimental periodontitis model.
<h4>Aims</h4>The aim of this study was to evaluate the effects of azilsartan (AZT) on bone loss, inflammation, and the expression of matrix metallo proteinases (MMPs), receptor activator of nuclear factor κB ligand (RANKL), receptor activator of nuclear factor κB (RANK), osteoprotegerin...
Guardado en:
Autores principales: | Aurigena Antunes de Araújo, Hugo Varela, Gerly Anne de Castro Brito, Caroline Addison Carvalho Xavier de Medeiros, Lorena de Souza Araújo, José Heriberto Oliveira do Nascimento, Raimundo Fernandes de Araújo Júnior |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1a7d800fce3a4ba397ec52b701f69b19 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
RANKL/OPG ratio regulates odontoclastogenesis in damaged dental pulp
por: Daisuke Nishida, et al.
Publicado: (2021) -
Vertebral osteomyelitis is characterised by increased RANK/OPG and RANKL/OPG expression ratios in vertebral bodies and intervertebral discs
por: S Lang, et al.
Publicado: (2021) -
Prevalence of polymorphisms in OPG, RANKL and RANK as potential markers for Charcot arthropathy development
por: Bożena Bruhn-Olszewska, et al.
Publicado: (2017) -
Regulation of MT1-MMP/MMP-2/TIMP-2 axis in human placenta
por: Vincent ZL, et al.
Publicado: (2015) -
Novel STAT binding elements mediate IL-6 regulation of MMP-1 and MMP-3
por: Samuel J. Cutler, et al.
Publicado: (2017)